← 產業報告目錄
Biopharmaceutical Third-Party Logistics Market Size, Share & Trends Analysis Report by Supply Chain (Cold Chain, Non-cold Chain), By Service Type (Transportation, Warehousing & Storage), Region And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-23頁數 180報告編號 INSIGHTACE-f4332f540a
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Biopharmaceutical Third-Party Logistics Market on a global scale was estimated at USD 141.4 Bn in 2024 and is poised to attain USD 264.8 Bn by 2034, with a projected CAGR of 6.6% between 2025 and 2034.
At its core, Biopharmaceutical Third-Party Logistics pertains to landscape are surgingly turning to these solutions to meet contemporary demands.
The market's upward path is fueled by surging healthcare spending, technological evolution, and the surging focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region poised to deliver the strongest growth trajectory through the forecast period, fueled by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biopharmaceutical third-party logistics Market Snapshot
Chapter 4. Global Biopharmaceutical third-party logistics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Supply Chain Estimates & Trend Analysis
5.1. By Supply Chain & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Supply Chain:
5.2.1. Cold Chain
5.2.2. Non-cold Chain
Chapter 6. Market Segmentation 2: By Service Type Estimates & Trend Analysis
6.1. By Supply Chain & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Service Type:
6.2.1. Transportation
6.2.1.1. Air Freight
6.2.1.2. Sea Freight
6.2.1.3. Overland
6.2.2. Warehousing & Storage
6.2.3. Other Services
Chapter 7. Biopharmaceutical third-party logistics Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Biopharmaceutical third-party logistics Market revenue (US$ Million) estimates and forecasts By Supply Chain, 2021-2034
7.1.2. North America Biopharmaceutical third-party logistics Market revenue (US$ Million) estimates and forecasts By Service Type, 2021-2034
7.1.3. North America Biopharmaceutical third-party logistics Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe
7.2.1. Europe Biopharmaceutical third-party logistics Market revenue (US$ Million) by By Supply Chain, 2021-2034
7.2.2. Europe Biopharmaceutical third-party logistics Market revenue (US$ Million) estimates and forecasts By Service Type, 2021-2034
7.2.3. Europe Biopharmaceutical third-party logistics Market revenue (US$ Million) by country, 2021-2034
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. UK
7.2.3.7. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Biopharmaceutical third-party logistics Market revenue (US$ Million) by By Supply Chain, 2021-2034
7.3.2. Asia Pacific Biopharmaceutical third-party logistics Market revenue (US$ Million) estimates and forecasts By Service Type, 2021-2034
7.3.3. Asia Pacific Biopharmaceutical third-party logistics Market revenue (US$ Million) by country, 2021-2034
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America Biopharmaceutical third-party logistics Market revenue (US$ Million) by By Supply Chain, 2021-2034
7.4.2. Latin America Biopharmaceutical third-party logistics Market revenue (US$ Million) estimates and forecasts By Service Type, 2021-2034
7.4.3. Latin America Biopharmaceutical third-party logistics Market revenue (US$ Million) by country, (US$ Million) 2021-2034
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. Middle East & Africa
7.5.1. Middle East & Africa Biopharmaceutical third-party logistics Market revenue (US$ Million) by By Supply Chain, (US$ Million)
7.5.2. Middle East & Africa Biopharmaceutical third-party logistics Market revenue (US$ Million) estimates and forecasts By Service Type, 2021-2034
7.5.3. Middle East & Africa Biopharmaceutical third-party logistics Market revenue (US$ Million) by country, (US$ Million) 2021-2034
7.5.3.1. South Africa
7.5.3.2. GCC Countries
7.5.3.3. Rest of MEA
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. DHL International GmbH.
8.2.2. SF Express.
8.2.3. United Parcel Service of America, Inc.
8.2.4. AmerisourceBergen Corporation.
8.2.5. DB Schenker; Kuehne and Nagel; Kerry Logistics Network Ltd.
8.2.6. Agility
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們